Jeffrey L. Coleman

Jeffrey L. Coleman

Auto-generated profile, based on publicly available information

Jeffrey L. Coleman

Department of Integrative Biology and Biodiversity Center, University of Texas at Austin, Austin, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2013 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
PDF file
JCJeffrey L. Coleman
Jeffrey L. Coleman
Deepak ShuklaDeepak Shukla
Deepak Shukla
Despite recent advances in vaccine design and strategies, latent infection with herpes simplex virus (HSV) remains a formidable challenge. Approaches involving live-attenuated viruses and inactivated viral preparations were popular throughout the twentieth century. In the past ten years, many vaccine types, both prophylactic or therapeutic, have contained a replication-defective HSV, viral DNA or glycoproteins. New research focused on the mechanism of immune evasion by the virus has involved developing vaccines with various gene deletions and manipulations combined with the use of new and more specific adjuvants. In addition, new “prime-boost” methods of strengthening the vaccine efficacy have proven effective, but there have also been flaws with some recent strategies that appear to have compromised vaccine efficacy in humans. Given the complicated lifecycle of HSV and its unique way of spreading from cell-to-cell, it can be concluded that the development of an ideal vaccine needs new focus on cell-mediated immunity, better understanding of the latent viral genome and serious consideration of gender-based differences in immunity development among humans. This review summarizes recent developments made in the field and sheds light on some potentially new ways to conquer the problem including development of dual-action prophylactic microbicides that prohibit viral entry and, in addition, induce a strong antigen response.

25 November 2018 in The Anatomical Record
Verified
Journal Article
Closed access
PDF file
TMTesla Monson
Tesla Monson
JCJeffrey L. Coleman
Jeffrey L. Coleman
LHLeslea J. Hlusko
Leslea J. Hlusko

27 September 2023 in Evolutionary Ecology
Verified
Journal Article
Closed access
PDF file
JCJeffrey L. Coleman
Jeffrey L. Coleman
DCDavid C. Cannatella
David C. Cannatella

27 December 2024 in eLife
Verified
Journal Article
Open access
RTRebecca D Tarvin
Rebecca D Tarvin
JCJeffrey L Coleman
Jeffrey L Coleman
DDDavid A Donoso
David A Donoso
MBMileidy Betancourth-Cundar
Mileidy Betancourth-Cundar
KLKarem López-Hervas
Karem López-Hervas
RFRichard W Fitch
Richard W Fitch
Understanding the origins of novel, complex phenotypes is a major goal in evolutionary biology. Poison frogs of the family Dendrobatidae have evolved the novel ability to acquire alkaloids from their diet for chemical defense at least three times. However, taxon sampling for alkaloids has been biased towards colorful species, without similar attention paid to inconspicuous ones that are often assumed to be undefended. As a result, our understanding of how chemical defense evolved in this group is incomplete. Here, we provide new data showing that, in contrast to previous studies, species from each undefended poison frog clade have measurable yet low amounts of alkaloids. We confirm that undefended dendrobatids regularly consume mites and ants, which are known sources of alkaloids. Thus, our data suggest that diet is insufficient to explain the defended phenotype. Our data support the existence of a phenotypic intermediate between toxin consumption and sequestration — passive accumulation — that differs from sequestration in that it involves no derived forms of transport and storage mechanisms yet results in low levels of toxin accumulation. We discuss the concept of passive accumulation and its potential role in the origin of chemical defenses in poison frogs and other toxin-sequestering organisms. In light of ideas from pharmacokinetics, we incorporate new and old data from poison frogs into an evolutionary model that could help explain the origins of acquired chemical defenses in animals and provide insight into the molecular processes that govern the fate of ingested toxins.

14 March 2022 in Journal of Chemical Ecology
Verified
Journal Article
Closed access
PDF file
JCJeffrey L. Coleman
Jeffrey L. Coleman
DCDavid C. Cannatella
David C. Cannatella

12 March 2025 in Journal of Chemical Ecology
Verified
Journal Article
Closed access
PDF file
JCJeffrey L. Coleman
Jeffrey L. Coleman
SWSteven Y. Wang
Steven Y. Wang
PMPaul E. Marek
Paul E. Marek
CMColin R. Morrison
Colin R. Morrison
BSBrian E. Sedio
Brian E. Sedio
DCDavid C. Cannatella
David C. Cannatella